- Home
- WASH vs SEPN Comparison
WASH vs SEPN Comparison
Compare WASH & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- SEPN
- Stock Information
- Founded
- WASH 1800
- SEPN 2022
- Country
- WASH United States
- SEPN United States
- Employees
- WASH N/A
- SEPN N/A
- Industry
- WASH Major Banks
- SEPN
- Sector
- WASH Finance
- SEPN
- Exchange
- WASH Nasdaq
- SEPN NYSE
- Market Cap
- WASH 647.4M
- SEPN 631.0M
- IPO Year
- WASH N/A
- SEPN 2024
- Fundamental
- Price
- WASH $31.50
- SEPN $5.80
- Analyst Decision
- WASH Hold
- SEPN Buy
- Analyst Count
- WASH 1
- SEPN 4
- Target Price
- WASH $34.00
- SEPN $34.00
- AVG Volume (30 Days)
- WASH 189.5K
- SEPN 857.5K
- Earning Date
- WASH 01-29-2025
- SEPN 02-28-2025
- Dividend Yield
- WASH 7.11%
- SEPN N/A
- EPS Growth
- WASH N/A
- SEPN N/A
- EPS
- WASH N/A
- SEPN N/A
- Revenue
- WASH $98,251,000.00
- SEPN $981,000.00
- Revenue This Year
- WASH N/A
- SEPN $406.62
- Revenue Next Year
- WASH $9.92
- SEPN N/A
- P/E Ratio
- WASH N/A
- SEPN N/A
- Revenue Growth
- WASH N/A
- SEPN N/A
- 52 Week Low
- WASH $24.11
- SEPN $4.17
- 52 Week High
- WASH $40.59
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- WASH 40.45
- SEPN N/A
- Support Level
- WASH $32.14
- SEPN N/A
- Resistance Level
- WASH $33.16
- SEPN N/A
- Average True Range (ATR)
- WASH 0.89
- SEPN 0.00
- MACD
- WASH -0.12
- SEPN 0.00
- Stochastic Oscillator
- WASH 2.95
- SEPN 0.00
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.